Podcasts

Initiating Insulin in Type 2 Diabetes Patients Faculty: For Your Patient Insulin Pump Technology: Improving Quality of Life in Diabetes Faculty: Juan Frias, MD Glucodynamic Effects With Co-formulations and Insulin Faculty: Juan Frias, MD What Does the Future Hold for the SGLT2-Inhibitor Class? Faculty: Robert R. Henry, MD New Longer-Acting Insulin Therapies Faculty: Juan Frias, MD Innovative Duros Delivery Device: New Information Presented at ADA in San Diego Faculty: Robert R. Henry, MD New GLP-1 Data Presented at the ADA's 71st Scientific Sessions Faculty: Robert R. Henry, MD Beta-Cell Preservation: Reality or Wishful Thinking? Faculty: John B. Buse, MD, PhD A1c in the Post-ACCORD Era Faculty: John B. Buse, MD, PhD Pioglitazone and Bladder Cancer Faculty: John B. Buse, MD, PhD How Real is Cancer Risk With Certain Diabetes Medications? Faculty: John B. Buse, MD, PhD Look AHEAD Updates from the ADA's 71st Scientific Sessions Faculty: Dennis Kim, MD Does Bariatric Surgery Cure Type 2 Diabetes? Faculty: Dennis Kim, MD Future of Obesity Therapeutics and the FDA: An Experienced Perspective Faculty: Dennis Kim, MD Understanding GLP-1 Therapies and Blood Glucose Control Faculty: For Your Patient GLP-1 Agonists in Basal Insulin-Treated Type 2 Diabetes Patients Faculty: John Buse, MD, PhD SGLT-2 Update Faculty: John Buse, MD, PhD Hypoglycemia in the Setting of Type 2 Diabetes Faculty: John Buse, MD, PhD Successful Amylin Replacement Therapy for Your Type 2 Diabetes Patients Faculty: Patrick Boyle, MD ADA-EASD Consensus Treatment Algorithm for Type 2 Diabetes Faculty: John Buse, MD, PhD Beta-Cell Function and the Treatment of Type 2 Diabetes Faculty: David Kendall, MD Review of the Potential of SGLT-2 Inhibitors Faculty: Robert Henry, MD Review of Reports on Relationship Between Insulin Glargine and Cancer Faculty: John Buse, MD, PhD Successful Amylin Replacement Therapy for Your Type 1 Diabetes Patients Faculty: Patrick J. Boyle, MD Review of Diabetes Drug Safety Concerns Faculty: David Kendall, MD